Recently Updated Guidelines
Guidelines for Treatment of Cancer by Type
-
Acute Lymphoblastic Leukemia Version 1.2021
-
Acute Myeloid Leukemia Version 3.2021
-
Anal Carcinoma Version 1.2021
-
Basal Cell Skin Cancer Version 2.2021
-
B-Cell Lymphomas Version 3.2021
-
Bladder Cancer Version 2.2021
-
Breast Cancer Version 3.2021
-
Central Nervous System Cancers Version 4.2020
-
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Version 3.2021
-
Esophageal and Esophagogastric Junction Cancers Version 2.2021
-
Gastric Cancer Version 2.2021
-
Gestational Trophoblastic Neoplasia Version 2.2021
-
Hairy Cell Leukemia Version 2.2021
-
Head and Neck Cancers Version 2.2021
-
Hepatobiliary Cancers Version 1.2021
-
Histiocytic Neoplasms Version 1.2021
-
Hodgkin Lymphoma Version 3.2021
-
Kaposi Sarcoma Version 1.2021
-
Kidney Cancer Version 3.2021
-
Malignant Pleural Mesothelioma Version 2.2021
-
Melanoma: Cutaneous Version 2.2021
-
Melanoma: Uveal Version 1.2021
-
Merkel Cell Carcinoma Version 1.2021
-
Multiple Myeloma Version 5.2021
-
Non-Small Cell Lung Cancer Version 4.2021
-
Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Version 1.2021
-
Pancreatic Adenocarcinoma Version 2.2021
-
Pediatric Hodgkin Lymphoma Version 3.2021
-
Primary Cutaneous Lymphomas Version 2.2021
-
Prostate Cancer Version 2.2021
-
Small Bowel Adenocarcinoma Version 1.2021
-
Small Cell Lung Cancer Version 3.2021
-
Wilms Tumor (Nephroblastoma) Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Acute Lymphoblastic Leukemia Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Acute Myeloid Leukemia Version 3.2021
-
NCCN Guidelines with Evidence Blocks - Anal Carcinoma Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Basal Cell Skin Cancer Version 2.2021
-
NCCN Guidelines with Evidence Blocks - B-Cell Lymphomas Version 3.2021
-
NCCN Guidelines with Evidence Blocks - Bladder Cancer Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Breast Cancer Version 3.2021
-
NCCN Guidelines with Evidence Blocks - Central Nervous System Cancers Version 4.2020
-
NCCN Guidelines with Evidence Blocks - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Version 3.2021
-
NCCN Guidelines with Evidence Blocks - Esophageal and Esophagogastric Junction Cancers Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Gastric Cancer Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Gestational Trophoblastic Neoplasia Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Hairy Cell Leukemia Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Head and Neck Cancers Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Hepatobiliary Cancers Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Histiocytic Neoplasms Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Hodgkin Lymphoma Version 3.2021
-
NCCN Guidelines with Evidence Blocks - Kaposi Sarcoma Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Kidney Cancer Version 3.2021
-
NCCN Guidelines with Evidence Blocks - Malignant Pleural Mesothelioma Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Melanoma: Cutaneous Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Merkel Cell Carcinoma Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Multiple Myeloma Version 5.2021
-
NCCN Guidelines with Evidence Blocks - Non-Small Cell Lung Cancer Version 4.2021
-
NCCN Guidelines with Evidence Blocks - Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Pancreatic Adenocarcinoma Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Pediatric Hodgkin Lymphoma Version 3.2021
-
NCCN Guidelines with Evidence Blocks - Primary Cutaneous Lymphomas Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Prostate Cancer Version 2.2021
-
NCCN Guidelines with Evidence Blocks - Small Bowel Adenocarcinoma Version 1.2021
-
NCCN Guidelines with Evidence Blocks - Small Cell Lung Cancer Version 3.2021
-
Prostate Cancer Version 2.2021
-
Prostate Cancer Version 2.2021
Guidelines for Detection, Prevention, & Risk Reduction
-
Breast Cancer Risk Reduction Version 1.2021
-
Colorectal Cancer Screening Version 1.2021
Guidelines for Supportive Care
-
Adult Cancer Pain Version 1.2021
-
Cancer-Associated Venous Thromboembolic Disease Version 1.2021
-
Hematopoietic Growth Factors Version 2.2021
-
Management of Immunotherapy-Related Toxicities Version 2.2021
-
Palliative Care Version 2.2021
-
Smoking Cessation Version 1.2021
-
Survivorship Version 1.2021
-
Survivorship Version 1.2021